Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | -5.00% |
|
-5.00% | 0.00% |
19/06 | Tryptamine Therapeutics Partners with Lucid Health to Advance TRP-8803's Product Registration in Australia | MT |
29/05 | Tryptamine Therapeutics Begins to Trade on ASX; Shares Surge 118% | MT |
Chart calendar Tryptamine Therapeutics Limited
Upcoming events on Tryptamine Therapeutics Limited
Past events on Tryptamine Therapeutics Limited
28/05/2024 11:35 am | Q4 2024 Earnings Release |
29/04/2024 07:26 pm | Q2 2024 Earnings Release |
08/03/2024 08:30 pm | Annual General Meeting |
Annual results
Fiscal Period | August | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million CAD | Released Forecast Spread | -7,29 -6,77 -7.64% | -7,36 -6,27 -17.43% | -5,25 -4,67 -12.37% | -5,10 |
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -8,25 -7,72 -7% | -7,49 -6,27 -19.58% | -5,27 -4,61 -14.15% | -5,10 |
Net income Million CAD | Released Forecast Spread | -8,25 -7,72 -7% | -7,49 -6,27 -19.58% | -5,27 -4,49 -17.41% | -5,10 |
EPS | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Announcement Date | 22/12/21 | 13/12/22 | 29/12/23 | - |
Quarterly results
Fiscal Period | August | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | ||
EBIT Million CAD | Released Forecast Spread | -1,55 -3,34 53.57% | -2,10 -1,01 -108.15% | -1,62 -1,65 1.92% | -1,27 -1,91 33.63% | -1,59 -1,02 -56.5% | -1,13 -1,09 -3.94% | -0,94 -1,16 19.23% | -1,33 | -1,52 | ||
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -1,56 -3,33 53.23% | -2,17 -1,01 -114.61% | -1,63 -1,65 0.83% | -1,29 -1,91 32.49% | -0,78 | -1,69 -1,02 -66.03% | -1,16 -1,09 -6.67% | -0,99 -1,16 15.03% | -1,33 | -1,52 | |
Net income Million CAD | Released Forecast Spread | -1,56 -3,33 53.23% | -0,75 | -2,17 -1,01 -114.61% | -1,63 -1,65 0.83% | -1,29 -1,91 32.49% | -0,66 | -1,69 -1,02 -66.03% | -1,16 -1,09 -6.67% | -0,99 -1,16 15.03% | -1,33 | -1,52 |
Announcement Date | 29/04/22 | 28/07/22 | 13/12/22 | 25/01/23 | 28/04/23 | 31/07/23 | 29/12/23 | 05/02/24 | 29/04/24 | - | - |
15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Tryptamine Therapeutics Limited
07/06/2024 12:27 pm | POLARIS GROUP: May 2024 Sales and Revenue Release |
30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- TYP Stock
- Calendar Tryptamine Therapeutics Limited